期刊文献+

鸭乙型肝炎病毒cccDNA Taq Man荧光定量PCR的建立 被引量:1

Establishment of the method for detecting DHBV cccDNA by the TaqMan fluorescence quantitative PCR
原文传递
导出
摘要 目的建立鸭乙型肝炎病毒(DHBV)cccDNA TaqMan荧光定量PCR方法。方法用pUCm-T载体和PCR纯化产物连接,转染TOP10菌,筛选阳性菌落,提取质粒,制作外标准品;在DHBV基因组负链两侧设计一对引物,并在引物间设计和荧光标记一段TaqMan探针,严格优化反应物的组成和扩增条件,建立了DHBV cccDNA TaqMan荧光定量PCR方法。结果最低可检出10~4拷贝/ml;批内误差为0.2%~3.14%,批间误差为2.22%~4.43%;在10~5~10^(12)拷贝/ml之间与C_t值具有很好的线性[Ct=-2.8361 ln(x)+41.45,r=-0.9985]。结论该法是一种灵敏度高、特异性强、较为简便的DHBV cccDNA定量检测技术。 Objeelive To develop a fluorescence quantitative PCR based on TaqMan chemistry for quantification of duck hepatitis virus B(DHBV) covalently closed circular DNA(cccDNA). Methods The PCR fragment of DHBV DNA was cloned into vector pUCm-T. The recombinant plasmid was purified and subsequently quantified as HBV DNA standard. A pair of primers were designed from the two sides of the nick in the minus strand of DHBV-DNA and a TaqMan probe between the primers, modified with 6-FAM at 5'-end and TAMP, at its 3'-end, was designed to detect the PCR production during the PCR cycles. The experimental conditions and reagents of amplification were sophisticatedly optimized in order to produce perfect amplification efficiency and reduce non-specific amplification. Results The detectable limit of the assay was 104 copies/ml. A linear standard curve was obtained between 10s to 1012 copies/ml(Ct =-2.8361In(x) +41.45, r =-0.9985). The coefficient of variation was 0.2% to 3.14% and 2.22% to 4.43% for intra-and inter-assay, respectively. After a dynamic survey of the DHBV DNA content in the ducks serum, we found its peak value appeared in the second week after the birth. Conclusion The TaqMan FQ-PCR for quantification of DHBV cccDNA is a simple, highly sensitive and specific method.
出处 《中华微生物学和免疫学杂志》 CAS CSCD 北大核心 2007年第7期656-659,共4页 Chinese Journal of Microbiology and Immunology
关键词 乙型肝炎病毒 脱氧核糖核酸 共价闭合环状 聚合酶链反应 Duck Hepatitis B virus Covalently closed circular DNA(cccDNA) Fluorescence quantitative PCR
  • 相关文献

参考文献5

  • 1Buti M, Sanchez F, Cotrina M, et al. Quantitative hepatitis B virus DNA testing for the early prediction of the maintenance of response during lamivudine therapy in patients with chronic hepatitis B. J Infect Dis, 2001, 183(8): 1277-1280.
  • 2赵克开,缪晓辉,徐文胜.HepG2.2.15细胞内乙型肝炎病毒cccDNA的定量检测[J].中华传染病杂志,2005,23(1):6-9. 被引量:23
  • 3Yuen MF, Wong DK, Sum SS, et al. Effect of lamivudine therapy on the serum covalently closed-circular(cccDNA) of chronic hepatitis B infection. Am J Gastroenterol, 2005, 100(5): 1099-1103.
  • 4ZoulimF.从肝内病毒cccDNA的研究中对HBV持续感染的新观察[J].J Hepatol Online,2004,29:27-27.
  • 5陈智.乙型肝炎病毒cccDNA研究现状[J].中华传染病杂志,2003,21(1):8-10. 被引量:33

二级参考文献8

  • 1骆抗先.实验感染模型[A].骆抗先主编.乙型肝炎基础和临床:第2版[C].北京:人民卫生出版社,2001.74-84.
  • 2Lu X, Block TM, Gerlich WH. Protease-induced infectivity of hepatitis B virus for a human hepatoblastoma cell line. J Virol,1996, 70:2277-2285.
  • 3Addison WR, Walters KA, Wong WW, et al. Half-life of the duck hepatitis B virus covalently closed circular DNA pool in vivo following inhibition of viral replication. J Virol, 2002, 76:6356-6363.
  • 4He ML, Wu J, Chen Y, et al. A new and sensitive method for the quantification of HBV cccDNA by real-time PCR. Biochem Biophys Res Commun, 2002, 295:1102-1107.
  • 5Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in HepG2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci, 1987, 84:1005-1009.
  • 6Sells MA, Zelent AZ, Shvartsman M, et al. Replicative intermediates of hepatitis B virus in HepG2 cells that produce infectious virions. J Virol, 1988, 62:2836-2844.
  • 7Lampertico P, Malter JS, Gerber MA. Development and application of an in vitro model for screening anti-hepatitis B virus therapeutics. Hepatology, 1991, 13:422-426.
  • 8黄砚青 龚作炯 张希惠.乙型肝炎病毒共价闭合环状DNA的特异性检测[J].肝脏,2001,6:38-39.

共引文献52

同被引文献27

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部